{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:25:52Z","timestamp":1790166352138,"version":"4.1.0"},"reference-count":46,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR\u201015\u2010IDEX\u201001"],"award-info":[{"award-number":["ANR\u201015\u2010IDEX\u201001"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR\u201011\u2010LABX\u20100028\u201001"],"award-info":[{"award-number":["ANR\u201011\u2010LABX\u20100028\u201001"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["00057927"],"award-info":[{"award-number":["00057927"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:p>One of the crucial challenges in the clinical management of cancer is the resistance to chemotherapeutics. We recently demonstrated that the Hedgehog receptor Patched, which is overexpressed in many recurrent and metastatic cancers, is a multidrug transporter for chemotherapeutic agents such as doxorubicin. The present work provides evidences that Patched is expressed in adrenocortical carcinoma (ACC) patients, and is a major player of the doxorubicin efflux and the doxorubicin resistance in the human ACC cell line H295R. We discovered that methiothepin inhibits the doxorubicin efflux activity of Patched. This drug\u2010like molecule enhances the cytotoxic, pro\u2010apoptotic, antiproliferative and anticlonogenic effects of doxorubicin on ACC cells which endogenously overexpress Patched, and thereby mitigates the resistance of these cancer cells to doxorubicin. Moreover, we report that in mice the combination of methiothepin with doxorubicin prevents the development of xenografted ACC tumors more efficiently than doxorubicin alone by enhancing the accumulation of doxorubicin specifically in tumors without obvious undesirable side effects. Our results suggest that the use of an inhibitor of Patched drug efflux such as methiothepin in combination with doxorubicin could be a promising therapeutic option for adrenocortical carcinoma, and most likely also for other Patched\u2010expressing cancers.<\/jats:p>","DOI":"10.1002\/ijc.31296","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T09:16:47Z","timestamp":1517995007000},"page":"199-211","source":"Crossref","is-referenced-by-count":27,"title":["Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma <i>in vitro<\/i> and <i>in vivo<\/i>"],"prefix":"10.1002","volume":"143","author":[{"given":"Anida","family":"Hasanovic","sequence":"first","affiliation":[{"name":"Universit\u00e9 C\u00f4te d'Azur, Sophia Antipolis Valbonne France"},{"name":"CNRS UMR7275, Sophia Antipolis Valbonne France"},{"name":"NEOGENEX CNRS International Associated Laboratory Sophia Antipolis Valbonne France"},{"name":"Institut de Pharmacologie Mol\u00e9culaire et Cellulaire, Sophia Antipolis Valbonne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ruggiero","sequence":"additional","affiliation":[{"name":"Universit\u00e9 C\u00f4te d'Azur, Sophia Antipolis Valbonne France"},{"name":"CNRS UMR7275, Sophia Antipolis Valbonne France"},{"name":"NEOGENEX CNRS International Associated Laboratory Sophia Antipolis Valbonne France"},{"name":"Institut de Pharmacologie Mol\u00e9culaire et Cellulaire, Sophia Antipolis Valbonne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Jung","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Medizinische Klinik und Poliklinik IV, Ludwig\u2010Maximilians\u2010Universit\u00e4t Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Rapa","sequence":"additional","affiliation":[{"name":"Department of Oncology University of Turin at San Luigi Hospital, Orbassano Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Signetti","sequence":"additional","affiliation":[{"name":"Universit\u00e9 C\u00f4te d'Azur, Sophia Antipolis Valbonne France"},{"name":"CNRS UMR7275, Sophia Antipolis Valbonne France"},{"name":"NEOGENEX CNRS International Associated Laboratory Sophia Antipolis Valbonne France"},{"name":"Institut de Pharmacologie Mol\u00e9culaire et Cellulaire, Sophia Antipolis Valbonne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Ben Hadj","sequence":"additional","affiliation":[{"name":"Universit\u00e9 C\u00f4te d'Azur, Sophia Antipolis Valbonne France"},{"name":"CNRS UMR7275, Sophia Antipolis Valbonne France"},{"name":"NEOGENEX CNRS International Associated Laboratory Sophia Antipolis Valbonne France"},{"name":"Institut de Pharmacologie Mol\u00e9culaire et Cellulaire, Sophia Antipolis Valbonne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Terzolo","sequence":"additional","affiliation":[{"name":"Department of Oncology University of Turin at San Luigi Hospital, Orbassano Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Medizinische Klinik und Poliklinik IV, Ludwig\u2010Maximilians\u2010Universit\u00e4t Munich Germany"},{"name":"Klinik f\u00fcr Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung, Universit\u00e4tsspital Z\u00fcrich Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Volante","sequence":"additional","affiliation":[{"name":"Department of Oncology University of Turin at San Luigi Hospital, Orbassano Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Hantel","sequence":"additional","affiliation":[{"name":"Endocrine Research Unit, Medizinische Klinik und Poliklinik IV, Ludwig\u2010Maximilians\u2010Universit\u00e4t Munich Germany"},{"name":"Klinik f\u00fcr Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung, Universit\u00e4tsspital Z\u00fcrich Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Lalli","sequence":"additional","affiliation":[{"name":"Universit\u00e9 C\u00f4te d'Azur, Sophia Antipolis Valbonne France"},{"name":"CNRS UMR7275, Sophia Antipolis Valbonne France"},{"name":"NEOGENEX CNRS International Associated Laboratory Sophia Antipolis Valbonne France"},{"name":"Institut de Pharmacologie Mol\u00e9culaire et Cellulaire, Sophia Antipolis Valbonne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5739-7684","authenticated-orcid":false,"given":"Isabelle","family":"Mus\u2010Veteau","sequence":"additional","affiliation":[{"name":"Universit\u00e9 C\u00f4te d'Azur, Sophia Antipolis Valbonne France"},{"name":"CNRS UMR7275, Sophia Antipolis Valbonne France"},{"name":"NEOGENEX CNRS International Associated Laboratory Sophia Antipolis Valbonne France"},{"name":"Institut de Pharmacologie Mol\u00e9culaire et Cellulaire, Sophia Antipolis Valbonne France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc706"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1984"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers6041925"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-015-0003-0"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000086183"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-11-0578"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1693608"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2009.03.007"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers7030851"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-368142"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S54702"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07737"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.375"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000336949"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-11-0305"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3637-3_19"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4162"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023834"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12685"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.3.14727"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-016-0273-2"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.3.10"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.66.2.268"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201541504"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-16-0249"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0439"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp100269f"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200966"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2013-1029"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-015-0240-3"},{"key":"e_1_2_7_32_1","first-page":"5488","article-title":"Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis","volume":"50","author":"Gazdar AF","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.08.041"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-11-0427"},{"key":"e_1_2_7_35_1","first-page":"351","article-title":"Adrenal cancer: scientific advances","author":"Hammer GD","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00501854"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(85)90128-5"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2011.09.038"},{"key":"e_1_2_7_39_1","first-page":"139","article-title":"On acute effects of some drugs on the higher nervous activity in man (the acoustic analyser). Clorotepin (0.5 mg and 1.0 mg), pemoline (100 mg). Part LI","volume":"111","author":"Hrbek J","year":"1985","journal-title":"Acta Univ Palacki Olomuc Fac Med"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30529"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2016.09.009"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2016.10.003"},{"key":"e_1_2_7_43_1","first-page":"1009","article-title":"P\u2010glycoprotein expression and activity of resistance modifying agents in primary cultures of human renal and adrenocortical carcinoma cells","volume":"14","author":"Fridborg H","year":"1994","journal-title":"Anticancer Res"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-007-9086-x"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2015.08.004"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7289"},{"key":"e_1_2_7_47_1","first-page":"370","article-title":"pH sensing and regulation in cancer","volume":"17","author":"Damaghi M","year":"2013","journal-title":"Front Physiol"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.31296","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.31296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T19:45:03Z","timestamp":1695498303000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.31296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1002\/ijc.31296"],"URL":"https:\/\/doi.org\/10.1002\/ijc.31296","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]}}}